GEN-MKT-18-7897-A
Feb 7, 2025 | Blogs, Life Science Research, Proteomics, ZenoTOF 7600+ system | 0 comments
Read time: 2 minutes
In a recent presentation, Tim Heymann from Mann Lab at the Max Planck Institute of Biochemistry shared his first impressions of ZT Scan DIA, the novel data-independent acquisition strategy from SCIEX, highlighting its innovative approach and significant benefits for proteomics research. Let’s dive into the key points from his insightful talk.
Understanding ZT Scan DIA
ZT Scan DIA offers a more efficient scan mode than regular SWATH DIA. The major difference lies in the continuous scan with overlapping windows, which eliminates overhead time and provides an additional Q1 scanning dimension. This results in a more efficient and detailed analysis, allowing researchers to distinguish between different precursors even if they appear to coelute.
Benchmarking ZT Scan DIA
Tim’s initial benchmarks focused on three performance assessments with a K562 digest: bulk-level analysis, lower sample inputs and short gradients. Using the Evosep One system coupled to the ZenoTOF 7600+ system, he tested various setups for higher coverage and throughput. The results were promising, showing a noticeable increase in identifications (IDs) at both the precursor and protein group levels.
Performance at different loads and gradients
ZT Scan DIA significantly boosted performance, especially at lower sample loads and shorter LC gradients. For instance, at 50 nanograms, there was a 50% gain in protein IDs, and at 500 SPD, the increase in quantifiable precursors was almost 100%. This robust performance across different settings highlights the versatility and efficiency of ZT Scan DIA.
Insights into phosphoproteomics
When analyzing phosphopeptides, ZT Scan DIA showed more than 10% gains in phosphosite detections, particularly in the lower abundant range. Although the overlap with Zeno SWATH DIA was lower, this was expected due to the enrichment process in phosphoproteomics. The enhanced selectivity of ZT Scan DIA provides more confidence in identifying phosphosites.
Leveraging AlphaDIA and Transfer Learning for data processing
Tim also discussed using AlphaDIA and Transfer Learning to maximize data analysis. By adapting models to different patterns and setups, AlphaDIA can significantly improve identification rates. Although current limitations prevent full access to the Q1 scanning dimension, ongoing developments promise even better performance in the future.
Conclusion
Overall, ZT Scan DIA represents a substantial advancement in proteomics research. It offers a performance boost that becomes more pronounced at lower loads and faster gradients. With its innovative approach and robust results, ZT Scan DIA is poised to impact the field significantly.
Watch Tim’s presentation here
Related links:
Technical overview: Continuing the data-independent acquisition (r)evolution: Introducing ZT Scan DIA for quantitative proteomics
Nature Portfolio article: Fast, sensitive or accurate? Proteomics researchers can now have all three.
In monoclonal antibody (mAb) development, assessment of purity and integrity of the protein in question is critical. CE‑SDS is the gold standard assay and is routinely run from analytical development through QC and lot release. It’s trusted because it consistently delivers quantitative, size‑based insight into purity and fragmentation, and it fits naturally into regulated environments.
In drug discovery and development, Metabolite Identification (Met ID) plays a critical role in understanding biotransformation pathways, ensuring safety, and meeting regulatory requirements. Advanced mass spectrometry techniques have revolutionized this process, particularly through electron-based fragmentation methods such as Electron Activated Dissociation (EAD) and Electron Transfer Dissociation (ETD). While both techniques leverage electron interactions to generate informative fragment ions, they differ significantly in mechanism, performance, and suitability for Met ID workflows.
In analytical laboratories, performance is not optional. Whether supporting regulated pharmaceutical workflows, high-throughput CRO operations, clinical reporting, or food and environmental testing, your mass spectrometry and capillary electrophoresis systems are critical to productivity, compliance, and scientific confidence.
Posted by
You must be logged in to post a comment.
Share this post with your network